Will natural products remain an important source of drug research for the future?

This publication has 23 references indexed in Scilit:

• Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: New antirejection drugs
  Expert Opinion on Therapeutic Patents, 1996
• Syntheses and Structure−Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity against Drug-Resistant Cancer Cells
  Journal of Medicinal Chemistry, 1996
• Chapter 34. To Market, To Market - 1995
  Published by Elsevier ,1996
• Docetaxel < Prop INN; USAN >
  Drugs of the Future, 1995
• Identification and characterization of a novel diketopiperazine as a modulator of P-glycoprotein-mediated multidrug resistance
  Anti-Cancer Drugs, 1994
• Comparison of Topoisomerase I Inhibition, DNA Damage, and Cytotoxicity of Camptothecin Derivatives Presently in Clinical Trials
  JNCI Journal of the National Cancer Institute, 1994
• Marine animal and terrestrial plant anticancer constituents
  Published by Walter de Gruyter GmbH ,1994
• Chapter 34. To Market, To Market - 1993
  Published by Elsevier ,1994
• The Current Status of Camptothecin Analogues as Antitumor Agents
  JNCI Journal of the National Cancer Institute, 1993
• Chapter 32. Taxol: From Discovery to Therapeutic Use
  Published by Elsevier ,1993